# Targeted Fusion Biopsy of the Prostate

> **NCT02744534** · PHASE2 · COMPLETED · sponsor: **Emory University** · enrollment: 21 (actual)

## Conditions studied

- Prostatic Neoplasms

## Interventions

- **DRUG:** FACBC PET-CT Scan
- **PROCEDURE:** Three-dimensional ultrasound-guided biopsy
- **PROCEDURE:** Standard transrectal ultrasound (TRUS) guided biopsy

## Key facts

- **NCT ID:** NCT02744534
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2018-03-31
- **Final completion:** 2018-03-31
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2019-05-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02744534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02744534, "Targeted Fusion Biopsy of the Prostate". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02744534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*